Jannick Prentoe

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Advanced Non Small Cell Lung Cancer

Health Promotion

Hepatitis C Virus

Human Immunodeficiency Virus

Top Venues

Science advances

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Elias Honerød Augestad, Christina Holmboe Olesen, Christina Grønberg, Andreas Soerensen, Rodrigo Velázquez-Moctezuma, Margherita Fanalista, Jens Bukh, Kaituo Wang, Pontus Emanuel Gourdon, Jannick Prentoe
The hepatitis C virus envelope protein complex is a dimer of heterodimers. Nature (2024)
Laura Collignon, Kenn Holmbeck, Ashley Just, Lieven Verhoye, Rodrigo Velázquez-Moctezuma, Ulrik Fahnøe, Thomas H R Carlsen, Mansun Law, Jannick Prentoe, Troels Kasper Høyer Scheel, Judith Margarete Gottwein, Philip Meuleman, Jens Bukh
JFH1-based Core-NS2 genotype variants of HCV with genetic stability in vivo and in vitro: Important tools in the evaluation of virus neutralization. Hepatology (Baltimore, Md.) (2024)
Jannick Prentoe, Christoph M Janitzek, Rodrigo Velázquez-Moctezuma, Andreas Soerensen, Thomas Jørgensen, Stine Clemmensen, Vladislav Soroka, Susan Thrane, Thor Theander, Morten Agertoug Nielsen, Ali Salanti, Jens Bukh, Adam Frederik Sander
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers. NPJ vaccines 7 (1) (2022)
Rodrigo Velázquez-Moctezuma, Elias H Augestad, Matteo Castelli, Christina Holmboe Olesen, Nicola Clementi, Massimo Clementi, Nicasio Mancini, Jannick Prentoe
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies. Vaccines 9 (3) (2021)
Jannick Prentoe, Christoph M Janitzek, Rodrigo Velázquez-Moctezuma, Louise Goksøyr, Rebecca W Olsen, Margherita Fanalista, Elias H Augestad, Susan Thrane, Anne F Pihl, Judith M Gottwein, Adam F Sander, Jens Bukh
Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens. PloS one 16 (7) (2021)
Netanel Tzarum, Erick Giang, Rameshwar U Kadam, Fang Chen, Kenna Nagy, Elias Honerød Augestad, Rodrigo Velázquez-Moctezuma, Zhen-Yong Keck, Yuanzi Hua, Robyn L Stanfield, Marlène Dreux, Jannick Prentoe, Steven K H Foung, Jens Bukh, Ian A Wilson, Mansun Law
An alternate conformation of HCV E2 neutralizing face as an additional vaccine target. Science advances 6 (30) (2020)
Elias Honerød Augestad, Matteo Castelli, Nicola Clementi, Luisa J Ströh, Thomas Krey, Roberto Burioni, Nicasio Mancini, Jens Bukh, Jannick Prentoe
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity. Science advances 6 (35) (2020)
Anna Czarnota, Anna Offersgaard, Anne Finne Pihl, Jannick Prentoe, Jens Bukh, Judith Margarete Gottwein, Krystyna Bieńkowska-Szewczyk, Katarzyna Grzyb
Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency. Vaccines 8 (2) (2020)
Jannick Prentoe, Rodrigo Velázquez-Moctezuma, Elias H Augestad, Andrea Galli, Richard Wang, Mansun Law, Harvey Alter, Jens Bukh
Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations. Proceedings of the National Academy of Sciences of the United States of America 116 (20) (2019)
Zhen-Yong Keck, Brian G Pierce, Patrick Lau, Janine Lu, Yong Wang, Alexander P Underwood, Rowena A Bull, Jannick Prentoe, Rodrigo Velázquez-Moctezuma, Melanie R Walker, Fabio Luciani, Johnathan D Guest, Catherine Fauvelle, Thomas F Baumert, Jens Bukh, Andrew R Lloyd, Steven K H Foung
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design. PLoS pathogens 15 (5) (2019)
Rodrigo Velázquez-Moctezuma, Andrea Galli, Mansun Law, Jens Bukh, Jannick Prentoe
Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms. Journal of virology 93 (4) (2019)
Netanel Tzarum, Erick Giang, Leopold Kong, Linling He, Jannick Prentoe, Elias Honerød Augestad, Yuanzi Hua, Shaun Castillo, Georg Michael Lauer, Jens Bukh, Jiang Zhu, Ian A Wilson, Mansun Law
Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies. Science advances 5 (1) (2019)
Rodrigo Velázquez-Moctezuma, Mansun Law, Jens Bukh, Jannick Prentoe
Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A. PLoS pathogens 13 (2) (2017)